Trial intelligence / Profile preview

Preventing Recurrent Gestational Diabetes Mellitus with Early Metformin Intervention

2014-001244-38Phase 4Unknown

Sponsor
Imperial College London
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of metformin in gestational diabetes mellitus (GDM), sponsored by Imperial College London. Primary endpoint: Development of gestational diabetes mellitus. Status: unknown.

02

Drugs

metformin
03

Conditions

gestational diabetes mellitus (GDM)

Beyond the preview

Go deeper on 2014-001244-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-001244-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call